• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Introduction to 1,5-Dimethyl-1H-pyrazole-4-carboxamide (CAS No. 103589-70-4)

1,5-Dimethyl-1H-pyrazole-4-carboxamide (CAS No. 103589-70-4) is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its unique structural properties and potential biological activities. This compound belongs to the pyrazole class, which is known for its broad spectrum of biological functions and utility in drug development. The presence of both methyl groups at the 1 and 5 positions, along with a carboxamide functional group at the 4 position, imparts distinct chemical and pharmacological characteristics that make it a promising candidate for further investigation.

The chemical structure of 1,5-Dimethyl-1H-pyrazole-4-carboxamide consists of a six-membered aromatic ring containing two nitrogen atoms, with methyl substituents at the 1 and 5 positions and a carboxamide group at the 4 position. This arrangement contributes to its stability and reactivity, making it a versatile intermediate in organic synthesis. The compound's solubility profile and interaction with biological targets are influenced by these structural features, which are critical factors in evaluating its pharmacological potential.

In recent years, there has been growing interest in pyrazole derivatives due to their role as scaffolds in the development of novel therapeutic agents. 1,5-Dimethyl-1H-pyrazole-4-carboxamide has been studied for its potential applications in various therapeutic areas, including anti-inflammatory, antimicrobial, and anticancer therapies. Its ability to modulate biological pathways makes it an attractive compound for drug discovery efforts.

One of the most compelling aspects of 1,5-Dimethyl-1H-pyrazole-4-carboxamide is its reported interaction with enzymes and receptors involved in disease processes. For instance, studies have suggested that this compound may inhibit certain kinases and other enzymes that are overexpressed in cancer cells. Additionally, its structural similarity to known bioactive molecules has prompted researchers to explore its potential as a lead compound for further optimization.

The synthesis of 1,5-Dimethyl-1H-pyrazole-4-carboxamide involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate precursors followed by functional group transformations. Advances in synthetic methodologies have enabled more efficient production of this compound, facilitating its use in both academic research and industrial applications.

Recent research has also highlighted the importance of 1,5-Dimethyl-1H-pyrazole-4-carboxamide in drug discovery due to its ability to exhibit multiple modes of action. This polypharmacological activity can be particularly advantageous in treating complex diseases that involve multiple pathological pathways. For example, studies have shown that this compound may have dual inhibitory effects on both inflammatory cytokines and growth factor receptors.

The pharmacokinetic properties of 1,5-Dimethyl-1H-pyrazole-4-carboxamide are another area of active investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for assessing its therapeutic potential and safety profile. Preliminary studies suggest that it exhibits reasonable oral bioavailability and moderate metabolic stability, making it a promising candidate for further development.

In conclusion, 1,5-Dimethyl-1H-pyrazole-4-carboxamide (CAS No. 103589-70-4) represents a significant advancement in pharmaceutical chemistry due to its unique structure and diverse biological activities. Its potential applications in treating various diseases make it a valuable compound for ongoing research and development efforts. As more data becomes available on its pharmacological properties and synthetic pathways, it is likely that this compound will play an increasingly important role in the discovery of new therapeutic agents.

• 2644-93-1(1,3,5-Trimethyl-1H-pyrazole-4-carbaldehyde)
• 494217-15-1(1,3-dimethyl-N-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-pyrazole-4-carboxamide)
• 1005694-72-3((1-ethyl-5-methyl-1H-pyrazol-4-yl)(4-methyl-1H-pyrazol-1-yl)methanone)
• 400756-31-2(1-(1,5-dimethyl-1H-pyrazol-4-yl)methanamine)
• 25711-30-2(1,5-Dimethyl-1H-pyrazole-4-carbaldehyde)
• 512810-25-2(1,3-dimethyl-1h-pyrazole-4-carbohydrazide)
• 861586-14-3(1H-Pyrazole-4-carboxamide,1,3,5-trimethyl-)
• 864948-68-5(1,5-Dimethyl-1H-pyrazole-4-carbohydrazide)
• 477711-16-3(1,3,5-trimethyl-1H-pyrazole-4-carbohydrazide)
• 124845-21-2(1,3-dimethyl-1H-pyrazole-4-carboxamide)